BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8630958)

  • 1. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
    Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
    Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.
    Waggoner SE; Anderson SM; Van Eyck S; Fuller J; Luce MC; Herbst AL
    Obstet Gynecol; 1994 Sep; 84(3):404-8. PubMed ID: 8058239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix.
    Waggoner SE; Anderson SM; Luce MC; Takahashi H; Boyd J
    Gynecol Oncol; 1996 Mar; 60(3):339-44. PubMed ID: 8774636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women.
    DeMars LR; Van Le L; Huang I; Fowler WC
    Gynecol Oncol; 1995 Sep; 58(3):389-92. PubMed ID: 7672708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
    van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
    Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
    Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
    Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
    Edelman DA
    Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.
    Melnick S; Cole P; Anderson D; Herbst A
    N Engl J Med; 1987 Feb; 316(9):514-6. PubMed ID: 3807995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and management of DES-exposed women.
    Vieiralves-Wiltgen C; Engle VF
    Nurse Pract; 1988 Nov; 13(11):15-6, 19-20, 22 passim. PubMed ID: 3231355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
    Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD
    Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diethylstilbestrol in pregnancy: an update.
    Kinch RA
    Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol].
    Schreiner WE; Bronz L; Wyss-Bernet M; Genton CY
    Schweiz Med Wochenschr; 1985 Nov; 115(44):1555-61. PubMed ID: 3841230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.
    Laronda MM; Unno K; Butler LM; Kurita T
    Differentiation; 2012 Oct; 84(3):252-60. PubMed ID: 22682699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological studies of the effects of diethylstilboestrol.
    Vessey MP
    IARC Sci Publ; 1989; (96):335-48. PubMed ID: 2680951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium.
    Larson PS; Ungarelli RA; de Las Morenas A; Cupples LA; Rowlings K; Palmer JR; Rosenberg CL
    Cancer; 2006 Nov; 107(9):2122-6. PubMed ID: 16998936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero.
    Mittendorf R
    Teratology; 1995 Jun; 51(6):435-45. PubMed ID: 7502243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.